Analyst Viewpoint
Increase in research activities in microbiome studies and surge in prevalence of infectious diseases are boosting the metagenomics market size.
Metagenomics is one of the fastest-growing scientific disciplines and is helping identify novel pathogens and study zoonotic reservoirs to help predict and prevent outbreaks.
Emergence of COVID-19 pandemic is likely to offer lucrative metagenomics market opportunities to vendors. Microbiome profiling using shotgun metagenomic sequencing can be employed to identify unique microorganisms in COVID-19 patients.
Key players operating in the global metagenomics market are offering NGS-based, clinical metagenomics technology suites for clinical laboratories.
They are also providing versatile sequencing platforms suitable for a wide range of applications, including de novo sequencing and assembly of genomic DNA.
Metagenomics is the study of the collective genomes of the members of a microbial community. Microorganisms constitute the majority of the Earth's biological diversity.
Metagenomics is the genomic analysis of microorganisms by direct extraction and cloning of DNA from their natural environment. It involves cloning and analyzing the genomes without culturing the organisms in the community.
Metagenomics in clinical diagnosis is helping evolve diagnosis and treatment approaches for infectious diseases. It is employed in in a wide range of areas including antimicrobial resistance, the microbiome, human host gene expression (transcriptomics), and oncology.
Metagenomics can facilitate function-based screenings for the discovery of novel proteins such as antibiotics. Rise in cases of drug resistance is expected to spur the metagenomics market growth in the near future as metagenomics is a promising tool for identifying and understanding antibiotic resistance mechanisms.
| Attribute | Detail |
|---|---|
| Drivers |
|
Microbiome studies focus on the collective genomes of microorganisms including bacteria, viruses, and fungi. These studies explore microorganisms inhabiting a particular environment such as the human body, soil, water, air, and various organisms.
Metagenomics is gaining traction in microbiome studies since it enables the analysis of all microorganisms, regardless of their ability to be cultured.
Metagenomics has wide applications in the fields of ecology & environment, drug discovery, clinical diagnostics, and food & beverages.
Major steps in metagenomic studies include sampling, sequencing, sequence read processing, assembly, gene prediction, binning, and functional annotation. Various types of metagenomic sequencing are used in metagenomics such as 165 sequencing, whole genome sequencing, and shotgun sequencing.
Rise in investment in microbiome research is propelling the metagenomics market demand. In October 2023, Leucine Rich Bio, an Indian microbiome company, raised an undisclosed amount in a pre-series A round of funding. The company intends to utilize funds for the development and marketing of new products.
Clinical metagenomics is an emerging approach employed in the diagnosis of infectious diseases. It involves the use of Next-generation Sequencing (NGS) technology to identify the etiologic agents to allow for more effective and targeted treatment of infectious diseases.
Clinical metagenomics can be employed to study Central Nervous System (CNS) infections. It can also be used to explore Bone and Joint Infections (BJIs).
High prevalence of BJIs is boosting the metagenomics market dynamics. Approximately 20,000 cases of septic arthritis occur in the U.S. each year (7.8 cases per 100,000 person-years), with a similar incidence occurring in Europe. Septic arthritis is increasingly common among persons older than 65 years, among immunosuppressed individuals.
Future trends in metagenomics market technologies are offering access to previously unexplored volumes of sequence space from uncultured organisms. This, in turn, has opened up many new avenues of research, with the number of projects and potential applications of metagenomics expanding.
Metagenomics can help researchers analyze microbiome differences between individuals with severe or mild COVID-19. Metagenomics approaches can aid in exploring the gut microbiome in COVID-19 patients. This, in turn, is expected to help research in the fight against the SARS-CoV-2 infection.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest metagenomics market trends, North America held largest share in 2022. Technological advancements and high adoption rate of metagenomics sequencing are driving the market statistics in the region. The U.S. is investing in R&D activities to allow for improved responsiveness to disease outbreaks.
In January 2024, the U.K. announced a new Strategic Dialogue on Biological Security with the U.S. to protect from increased biological threats.
The partnership promotes responsible innovation in the biotechnology, health, and life sciences sectors to shape norms and standards on biosafety and biosecurity. Such initiatives are augmenting the metagenomics market share in North America as well as Europe.
Companies operating in the metagenomics market landscape are offering sample preparation automation for standardization and reliability. They are also providing an extensive range of microbiome solutions such as NGS, digital PCR (dPCR), and quantitative PCR (qPCR) to cater to various microbiome studies.
Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., Promega Corporation, Novogene Co., Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Arc Bio, LLC, Eurofins Scientific, Zymo Research, Microsynth AG, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., and Computomics GmbH are key players operating in the metagenomics industry.
Each of these companies has been profiled in the metagenomics market report based on parameters such as company overview, business strategies, financial overview, business segments, product portfolio, and recent developments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 1.6 Bn |
| Market Forecast (Value) in 2031 | US$ 4.6 Bn |
| Growth Rate (CAGR) | 12.9% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 1.6 Bn in 2022
It is anticipated to advance at a CAGR of 12.9% from 2023 to 2031
Increase in research activities in microbiome studies and surge in prevalence of infectious diseases
North America was the most lucrative region in 2022
Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., Promega Corporation, Novogene Co., Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Arc Bio, LLC, Eurofins Scientific, Zymo Research, Microsynth AG, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., and Computomics GmbH
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Metagenomics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Metagenomics Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Metagenomics Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Instruments
6.3.2. Kits & Reagents
6.3.3. Software & Services
6.4. Market Attractiveness Analysis, by Product Type
7. Global Metagenomics Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2017–2031
7.3.1. 16S Sequencing
7.3.2. Whole Genome Sequencing
7.3.3. Shotgun Sequencing
7.3.4. Others
7.4. Market Attractiveness Analysis, by Technology
8. Global Metagenomics Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Ecology & Environment
8.3.2. Clinical Diagnostics
8.3.3. Drug Discovery
8.3.4. Biotechnology
8.3.5. Food & Beverages
8.3.6. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Metagenomics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Metagenomics Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2017–2031
10.3.1. Instruments
10.3.2. Kits & Reagents
10.3.3. Software & Services
10.4. Market Value Forecast, by Technology, 2017–2031
10.4.1. 16S Sequencing
10.4.2. Whole Genome Sequencing
10.4.3. Shotgun Sequencing
10.4.4. Others
10.5. Market Value Forecast, by Application, 2017–2031
10.5.1. Ecology & Environment
10.5.2. Clinical Diagnostics
10.5.3. Drug Discovery
10.5.4. Biotechnology
10.5.5. Food & Beverages
10.5.6. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Technology
10.7.3. By Application
10.7.4. By Country
11. Europe Metagenomics Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2017–2031
11.3.1. Instruments
11.3.2. Kits & Reagents
11.3.3. Software & Services
11.4. Market Value Forecast, by Technology, 2017–2031
11.4.1. 16S Sequencing
11.4.2. Whole Genome Sequencing
11.4.3. Shotgun Sequencing
11.4.4. Others
11.5. Market Value Forecast, by Application, 2017–2031
11.5.1. Ecology & Environment
11.5.2. Clinical Diagnostics
11.5.3. Drug Discovery
11.5.4. Biotechnology
11.5.5. Food & Beverages
11.5.6. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Technology
11.7.3. By Application
11.7.4. By Country/Sub-region
12. Asia Pacific Metagenomics Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2017–2031
12.3.1. Instruments
12.3.2. Kits & Reagents
12.3.3. Software & Services
12.4. Market Value Forecast, by Technology, 2017–2031
12.4.1. 16S Sequencing
12.4.2. Whole Genome Sequencing
12.4.3. Shotgun Sequencing
12.4.4. Others
12.5. Market Value Forecast, by Application, 2017–2031
12.5.1. Ecology & Environment
12.5.2. Clinical Diagnostics
12.5.3. Drug Discovery
12.5.4. Biotechnology
12.5.5. Food & Beverages
12.5.6. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Technology
12.7.3. By Application
12.7.4. By Country/Sub-region
13. Latin America Metagenomics Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2017–2031
13.3.1. Instruments
13.3.2. Kits & Reagents
13.3.3. Software & Services
13.4. Market Value Forecast, by Technology, 2017–2031
13.4.1. 16S Sequencing
13.4.2. Whole Genome Sequencing
13.4.3. Shotgun Sequencing
13.4.4. Others
13.5. Market Value Forecast, by Application, 2017–2031
13.5.1. Ecology & Environment
13.5.2. Clinical Diagnostics
13.5.3. Drug Discovery
13.5.4. Biotechnology
13.5.5. Food & Beverages
13.5.6. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Technology
13.7.3. By Application
13.7.4. By Country/Sub-region
14. Middle East & Africa Metagenomics Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2017–2031
14.3.1. Instruments
14.3.2. Kits & Reagents
14.3.3. Software & Services
14.4. Market Value Forecast, by Technology, 2017–2031
14.4.1. 16S Sequencing
14.4.2. Whole Genome Sequencing
14.4.3. Shotgun Sequencing
14.4.4. Others
14.5. Market Value Forecast, by Application, 2017–2031
14.5.1. Ecology & Environment
14.5.2. Clinical Diagnostics
14.5.3. Drug Discovery
14.5.4. Biotechnology
14.5.5. Food & Beverages
14.5.6. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Technology
14.7.3. By Application
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Thermo Fisher Scientific, Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. QIAGEN
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Illumina, Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Promega Corporation
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Novogene Co., Ltd.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Takara Bio Inc.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Oxford Nanopore Technologies plc
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Arc Bio, LLC
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Eurofins Scientific
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Zymo Research
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Microsynth AG
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. F. Hoffmann-La Roche Ltd.
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
15.3.13. PerkinElmer, Inc.
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Financial Overview
15.3.13.5. Strategic Overview
15.3.14. Computomics GmbH
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Financial Overview
15.3.14.5. Strategic Overview
List of Tables
Table 01: Global Metagenomics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Metagenomics Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 03: Global Metagenomics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 04: Global Metagenomics Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Metagenomics Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Metagenomics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 07: North America Metagenomics Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 08: North America Metagenomics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 09: Europe Metagenomics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Metagenomics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11: Europe Metagenomics Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 12: Europe Metagenomics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 13: Asia Pacific Metagenomics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Metagenomics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Asia Pacific Metagenomics Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 16: Asia Pacific Metagenomics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 17: Latin America Metagenomics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Metagenomics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Latin America Metagenomics Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 20: Latin America Metagenomics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 21: Middle East & Africa Metagenomics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Metagenomics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23: Middle East & Africa Metagenomics Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 24: Middle East & Africa Metagenomics Market Size (US$ Mn) Forecast, by Application, 2017–2031
List of Figures
Figure 01: Global Metagenomics Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Metagenomics Market Revenue (US$ Mn), by Product Type, 2022
Figure 03: Global Metagenomics Market Value Share, by Product Type, 2022
Figure 04: Global Metagenomics Market Revenue (US$ Mn), by Technology, 2022
Figure 05: Global Metagenomics Market Value Share, by Technology, 2022
Figure 06: Global Metagenomics Market Revenue (US$ Mn), by Application, 2022
Figure 07: Global Metagenomics Market Value Share, by Application, 2022
Figure 08: Global Metagenomics Market Value Share, by Region, 2022
Figure 09: Global Metagenomics Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Global Metagenomics Market Value Share Analysis, by Product Type, 2022–2031
Figure 11: Global Metagenomics Market Attractiveness Analysis, by Product Type, 2020–2031
Figure 12: Global Metagenomics Market Value Share Analysis, by Technology, 2022–2031
Figure 13: Global Metagenomics Market Attractiveness Analysis, by Technology, 2020–2031
Figure 14: Global Metagenomics Market Value Share Analysis, by Application, 2022–2031
Figure 15: Global Metagenomics Market Attractiveness Analysis, by Application, 2020–2031
Figure 16: Global Metagenomics Market Value Share Analysis, by Region, 2022–2031
Figure 17: Global Metagenomics Market Attractiveness Analysis, by Region, 2020–2031
Figure 18: North America Metagenomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Metagenomics Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Metagenomics Market Value Share Analysis, by Country, 2022–2031
Figure 21: North America Metagenomics Market Value Share Analysis, by Product Type, 2022–2031
Figure 22: North America Metagenomics Market Value Share Analysis, by Technology, 2022–2031
Figure 23: North America Metagenomics Market Value Share Analysis, by Application, 2022–2031
Figure 24: North America Metagenomics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 25: North America Metagenomics Market Attractiveness Analysis, by Technology, 2023–2031
Figure 26: North America Metagenomics Market Attractiveness Analysis, by Application, 2023–2031
Figure 27: Europe Metagenomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Metagenomics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Metagenomics Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 30: Europe Metagenomics Market Value Share Analysis, by Product Type, 2022–2031
Figure 31: Europe Metagenomics Market Value Share Analysis, by Technology, 2022–2031
Figure 32: Europe Metagenomics Market Value Share Analysis, by Application, 2022–2031
Figure 33: Europe Metagenomics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 34: Europe Metagenomics Market Attractiveness Analysis, by Technology, 2023–2031
Figure 35: Europe Metagenomics Market Attractiveness Analysis, by Application, 2023–2031
Figure 36: Asia Pacific Metagenomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Metagenomics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Metagenomics Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 39: Asia Pacific Metagenomics Market Value Share Analysis, by Product Type, 2022–2031
Figure 40: Asia Pacific Metagenomics Market Value Share Analysis, by Technology, 2022–2031
Figure 41: Asia Pacific Metagenomics Market Value Share Analysis, by Application, 2022–2031
Figure 42: Asia Pacific Metagenomics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 43: Asia Pacific Metagenomics Market Attractiveness Analysis, by Technology, 2023–2031
Figure 44: Asia Pacific Metagenomics Market Attractiveness Analysis, by Application, 2023–2031
Figure 45: Latin America Metagenomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Metagenomics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Metagenomics Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 48: Latin America Metagenomics Market Value Share Analysis, by Product Type, 2022–2031
Figure 49: Latin America Metagenomics Market Value Share Analysis, by Technology, 2022–2031
Figure 50: Latin America Metagenomics Market Value Share Analysis, by Application, 2022–2031
Figure 51: Latin America Metagenomics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 52: Latin America Metagenomics Market Attractiveness Analysis, by Technology, 2023–2031
Figure 53: Latin America Metagenomics Market Attractiveness Analysis, by Application, 2023–2031
Figure 54: Middle East & Africa Metagenomics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Metagenomics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Metagenomics Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 57: Middle East & Africa Metagenomics Market Value Share Analysis, by Product Type, 2022–2031
Figure 58: Middle East & Africa Metagenomics Market Value Share Analysis, by Technology, 2022–2031
Figure 59: Middle East & Africa Metagenomics Market Value Share Analysis, by Application, 2022–2031
Figure 60: Middle East & Africa Metagenomics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 61: Middle East & Africa Metagenomics Market Attractiveness Analysis, by Technology, 2023–2031
Figure 62: Middle East & Africa Metagenomics Market Attractiveness Analysis, by Application, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Metagenomics Market
